CGTX
Cognition Therapeutics Inc
0.9251$
+3.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | +1.5% | -12.1% | +15.5% | +4.5% | +1.4% | -36.6% | +35.6% | +0.0% | +0.0% | +11.5% | – | – | |
| – | – | -119.0% | – | – | – | – | – | – | – | – | – | – | |
| – | -0.6% | -9.0% | +9.7% | -1.6% | -28.4% | +32.3% | +6.4% | -67.1% | +195.4% | -45.7% | -15.8% | – | |
| – | +16.7% | -1.1% | -12.6% | -1.0% | -16.3% | +16.3% | -16.5% | +4.2% | -3.0% | +6.9% | -2.1% | – | |
| – | +3.0% | -7.5% | +4.5% | -1.5% | -25.9% | +28.5% | +1.5% | -54.8% | +116.5% | -36.0% | -11.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +350.0% | +11.1% | -30.0% | -57.1% | +66.7% | +0.0% | -40.0% | -100.0% | – | +0.0% | -40.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +626.9% | -99.4% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.